BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 20727587)

  • 1. PLGA/polymeric liposome for targeted drug and gene co-delivery.
    Wang H; Zhao P; Su W; Wang S; Liao Z; Niu R; Chang J
    Biomaterials; 2010 Nov; 31(33):8741-8. PubMed ID: 20727587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-targeting magnetic core-shell nanocarriers for selective drug release and imaging.
    Wang H; Wang S; Liao Z; Zhao P; Su W; Niu R; Chang J
    Int J Pharm; 2012 Jul; 430(1-2):342-9. PubMed ID: 22525087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate targeted polymeric 'green' nanotherapy for cancer.
    Narayanan S; Binulal NS; Mony U; Manzoor K; Nair S; Menon D
    Nanotechnology; 2010 Jul; 21(28):285107. PubMed ID: 20585151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X; Zou W; Liu C; Zhang N; Fu C
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smart multifunctional core-shell nanospheres with drug and gene co-loaded for enhancing the therapeutic effect in a rat intracranial tumor model.
    Wang H; Su W; Wang S; Wang X; Liao Z; Kang C; Han L; Chang J; Wang G; Pu P
    Nanoscale; 2012 Oct; 4(20):6501-8. PubMed ID: 22961067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery.
    Wang H; Zhao P; Liang X; Gong X; Song T; Niu R; Chang J
    Biomaterials; 2010 May; 31(14):4129-38. PubMed ID: 20163853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
    Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
    Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCs.
    Jeon SY; Park JS; Yang HN; Woo DG; Park KH
    Biomaterials; 2012 Jun; 33(17):4413-23. PubMed ID: 22425025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer.
    Wang Y; Gao S; Ye WH; Yoon HS; Yang YY
    Nat Mater; 2006 Oct; 5(10):791-6. PubMed ID: 16998471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P; Xu Y; Zeng C; Ren H; Peng M
    Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene delivery using dimethyldidodecylammonium bromide-coated PLGA nanoparticles.
    Fay F; Quinn DJ; Gilmore BF; McCarron PA; Scott CJ
    Biomaterials; 2010 May; 31(14):4214-22. PubMed ID: 20185174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of biodegradable PLGA nanoparticles to mediate SOX9 gene delivery in human mesenchymal stem cells (hMSCs) and induce chondrogenesis.
    Kim JH; Park JS; Yang HN; Woo DG; Jeon SY; Do HJ; Lim HY; Kim JM; Park KH
    Biomaterials; 2011 Jan; 32(1):268-78. PubMed ID: 20875683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional core-shell polymeric nanoparticles for transdermal DNA delivery and epidermal Langerhans cells tracking.
    Lee PW; Hsu SH; Tsai JS; Chen FR; Huang PJ; Ke CJ; Liao ZX; Hsiao CW; Lin HJ; Sung HW
    Biomaterials; 2010 Mar; 31(8):2425-34. PubMed ID: 20034662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(D,L-lactide-co-glycolide acid) nanoparticles for DNA delivery: waiving preparation complexity and increasing efficiency.
    Gvili K; Benny O; Danino D; Machluf M
    Biopolymers; 2007 Apr 5-15; 85(5-6):379-91. PubMed ID: 17266128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium phosphate embedded PLGA nanoparticles: a promising gene delivery vector with high gene loading and transfection efficiency.
    Tang J; Chen JY; Liu J; Luo M; Wang YJ; Wei XW; Gao X; Wang BL; Liu YB; Yi T; Tong AP; Song XR; Xie YM; Zhao Y; Xiang M; Huang Y; Zheng Y
    Int J Pharm; 2012 Jul; 431(1-2):210-21. PubMed ID: 22561795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA.
    Nie H; Wang CH
    J Control Release; 2007 Jul; 120(1-2):111-21. PubMed ID: 17512077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.
    Aravind A; Jeyamohan P; Nair R; Veeranarayanan S; Nagaoka Y; Yoshida Y; Maekawa T; Kumar DS
    Biotechnol Bioeng; 2012 Nov; 109(11):2920-31. PubMed ID: 22615073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
    Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
    Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.